A controlled clinical exploratory study on genetic markers for peri-implantitis

European Journal of Oral Implantology

Volumn 4, Issue 4, 2011, Pages 371-382

  Hall, Jan ^a   Britse, Anna Örnhall ^b   Jemt, Torsten ^b,c   Friberg, Bertil ^b  

^a Nobel Biocare   (Sweden)

^b BRÅNEMARK CLINIC   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Bone resorption; Diagnosis; Peri implantitis; Qpcr

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CATHEPSIN K; CTSK PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; INTERLEUKIN 1BETA; ISOENZYME; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SIGNAL PEPTIDE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BONE REMODELING; CHEMISTRY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; FEASIBILITY STUDY; FEMALE; GENETIC MARKER; GENETICS; GINGIVITIS; HUMAN; MALE; METABOLISM; OSTEOLYSIS; PERIIMPLANTITIS; REAL TIME POLYMERASE CHAIN REACTION; SINGLE BLIND PROCEDURE; TOOTH IMPLANTATION;

ACID PHOSPHATASE; AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE REMODELING; BONE RESORPTION; CATHEPSIN K; CROSS-SECTIONAL STUDIES; DENTAL IMPLANTS; FEASIBILITY STUDIES; FEMALE; GENETIC MARKERS; GINGIVAL CREVICULAR FLUID; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; ISOENZYMES; MALE; OSTEOCALCIN; OSTEOPROTEGERIN; PERI-IMPLANTITIS; RANK LIGAND; REAL-TIME POLYMERASE CHAIN REACTION; SINGLE-BLIND METHOD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859385718     PISSN: 17562406     EISSN: 17562414     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Roos-Jansåker A-A, Lindahl C, Renvert H, Renvert S. Nine-to fourteen-year follow-up of implant treatment. Part I: implant loss and associations to various factors. J Clin Periodontol 2006;33:283-289.
2. Jung RE, Pjetrusson BE, Glauser R, Zembic A, Zwahlen M, Lang NP. A systematic review of 5-year survival and complication rates of implant-supported single crowns. Clin Oral Implants Res 2008;19:119-130.
3. Lang NP, Pjetrusson BE, Tan K, Brägger U, Egger M, Zwahlen M. A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. II. Combined tooth-implant-supported FPDs. Clin Oral Implants Res 2004;15:643-653.
4. Pjetrusson BE, Tan K, Lang NP, Brägger U, Egger M, Zwahlen M. A systematic review of the survival and complication rates of fixed partial dentures (FPDs) after an observation period of at least 5 years. I. Implant-suported FPDs. Clin Oral Implants Res 2004;15:625-642.
5. Quriynen M, De Soete M, van Steenberge D. Infectious risks for oral implants: a review of the literature. Clin Oral Implants Res 2002;13:1-19.
6. Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontol 2008;35(Suppl 8):316-332.
7. Zitzmann N, Berglundh T. Definition and prevalence of peri-implant disease. J Clin Periodontol 2008;35:286-291.
8. Hugosson A, Laurell L. A prospective longitudinal study on periodontal bone height chages in a Swedish population. J Clin Periodontol 2000;27:665-674.
9. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efficacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants 1986;1:11-25.
10. Albrektson T, Zarb GA. Current interpretations of the osseo-integrated response: clinical significance. Int J Prosthodont 1993;6:95-105.
11. Fransson C, Lekholm U, Jemt T, Berglundh T. Prevalence of subjects with progressive bone loss at implants. Clin Oral Implants Res 2005;16:440-446.
12. Fransson C, Wennström J, Berglundh T. Clinical characteristics at implants with a history of progressive bone loss. Clin Oral Implants Res 2008;19:142-147.
13. Karoussis IK, Brägger U, Salvi GE, Bürgin W, Lang NP. Effect of implant design on survival and success rates of titanium oral implants: a 10-year prospective cohort study of the ITI Dental Implant System. Clin Oral Implants Res 2004;15:8-17.
14. Heitz-Mayfield LJA. Peri-implant diseases: diagnosis and risk indicators. J Clin Periodontol 2008;35(Suppl 8):292-304.
15. Kao RT, Curtis DA, Richards DW, Preble J. Increased interleukin-1 B in the crevicular fluid of diseased implants. Int J Oral Maxillofac Implants 1995;10:696-701.
16. Lachmann S, Kimmerle-Müller E, Axmann D, Gomez-Roman G, Weber H, Haas R. Reliability of findings around healthy implants in association with oral hygiene measures: a clinical, microbiological, and immunological follow-up in edentulous patients. Clin Oral Implants Res 2007;18:686-698.
17. Goodson JM, Tanner ACR, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982;9:472-481.
18. Lindhe J, Haffajee AD, Socransky SS. Progression of periodontal disease in adult subjects in the absence of periodontal therapy. J Clin Periodontol 1983;10:433-442.
19. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodon-tol 1984;11:21-32.
20. Polizzi G, Rangert B, Lekholm U, Gualini F, Lindström H. Brånemark System(r) Wide Platform implants for single molar replacement: Clinical evaluation of prospective and retrospective materials. Clin Implant Dent Relat Res 2000;2:61-69.
21. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4:e297.
22. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P. Strengthening the reporting of observational studies in epidemiology - Molecular epidemiology (STROBE-ME): An extension of the STROBE statement. PLoS Med 2011;8:e1001117.
23. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method. Methods 2001;25:402-408.
24. NormFinder software. Available at: http://www.mdl.dk/publicationsnormfinder.htm. Accessed 29 November 2011.
25. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants 1996;11:794-799.
26. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, Takeda H, Araki H, Shin K, Okuda K, Miyata T, Yoshie H. Osteocalcin, deoxypyridinoline and interleukin-IB in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002;13:637-643.
27. Hultin M, Gustafsson A, Hallström H, Johansson L-Å, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002; 13:349-358.
28. Duarte PM, de Mendonça AC, Máximo MBB, Santos VR, Bastos MF, Nociti Júnior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009;20:514-520.
29. Ataoglu H, Ozlem Alptekin N, Haliloglu S, Ataoglu T, Serpek B, Durmus E. Interleukin-1 ß, tumor necrosis factor-a levels and neutrophil elastase activity in peri-implant crevicular fluid. Correlation with clinical parameters and effect of smoking. Clin Oral Implants Res 2002;13:470-476.
30. Boyle W, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
31. Leibbrandt A, Penninger JM. RANK/RANKL: Regulators of immune responses and bone physiology. Ann NY Acad Sci 2008;1143:123-150.
32. Chamoux E, Houde N, L'Eriger K, Roux S. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway. J Cell Physiol 2008;216:536-542.
33. Corralini F, Celeghini C, Rimondi E, di lasio MG, Gonelli A, Secchiero P, Zauli G. TRAIL down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. J Cell Physiol 2011;226:2279-2286.
34. Saidenberg Kermanac'h N, Bessis N, Cohen-Solal M, De Vernejoul MC, Boissier MC. Osteoprotegerin and inflammation. Eur Cytokine Netw 2002;13:144-153.
35. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Töz H, Atilla G, Hughes FJ, Belibasakis GN. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007;34:370-376.
36. Arikan F, Buduneli N, Kütükçüler N. Osteoprotegerin levels in peri-implant crevicular fluid. Clin Oral Implants Res 2008;19:283-288.
37. Monov G, Strbac GD, Baron M, Kandler B, Watzek G, Gruber R. Soluble RANKL in crevicular fluid of dental implants: a pilot study. Clin Implant Dent Relat Res 2006;8:135-141.
38. Liu YY, Long L, Wang SY, Guo JP, Ye H, Cui LF, Yuan GH, Li ZG. Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis. Chin Med J (Engl) 2010;123:1407-1412.
39. Willert K, Brown JD, Dananberg E, Duncan AW, Weisman IL, Raya T, Yates JR 3rd, Nusse R. Wnt proteins are lipidmodified and can act as stem cell growth factors. Nature 2003;423:448-452.
40. Yavropoulou MP, Yovos JG. The role of the Wnt signaling pathway in osteoblast commitment and differentiation. Hormones 2007;6:279-294.
41. Dalbeth N, Pool B, Callon KE, Lobo M, Taylor WJ, Jones PB, Cornish J, McQueen FM. Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion. Arthritis Res Ther 2010;12:R164.
42. Minkin C. Bone acid phosphatase: Tartrate-Resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982,34:285-290.
43. Strbac GD, Monov G, Cei S, Kandler B, Watzek G, Gruber R. Cathepsin K levels in the crevicular fluid of dental implants: a pilot study. J Clin Periodontol 2006;33:302-308.
44. Plagnat D, Giannopouou C, Carrel A, Bernard J-P, Belser UC. Elastase, a2-macroglobulin and alkaline phosphatase in crevicular fluid from implants with and without periimplantitis. Clin Oral Implants Res 2002;13:227-233.
45. Kinane DF, Preshaw PM, Loos BG. Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions - Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 2011;38(Suppl 11):44-48.
46. Mirrielees J, Crofford LJ, Lin Y Kryscio RJ, Dawson DR, Ebersole JL, Miller CS. Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol 2010; 37:1068-1074.
47. Mombelli A, van Oosten MA, Schurch E Jr, Lang NP. The microbiota associated with successful or failing osseo-integrated titanium implants. Oral Microbiol Immunol 1987; 2:145-151.